Korea Investment Partners — 2025 Investments
8 investments dated 2025 · listed companies and verified rows first · show all
Clarify builds a modern CRM platform that consolidates customer data from multiple sources, automates workflows, and provides insights to drive business growth.
AI & Machine LearningEnterprise SoftwareSaaSSales TechDover, US
Patrick Thompson(Founder)inOndrej Hrebicek(Founder)inAustin Hay(Founder)inPranav Priyush(CEO)
BoardMatt Garratt(Director)inZachary Bratun-Glennon(Director)in
Co-investorsAscend Venture CapitalEssence Venture CapitalFikaGradient VenturesInvariantes FundMadrona Venture Group+6 more
CoBX Bio is a drug discovery company working in chemical proteomics.
BiotechDeep Tech
Co-investorsAtinum Investment Co. Ltd.Kiwoom InvestmentCompany K PartnersKB InvestmentSolidus Investment
EGONGEGONG (이공이공) is a North American distribution and brand accelerator that sources Korean consumer products, launches them on Amazon and across US retail, and invests directly in the brands it grows.
ConsumerE-commerceRetail Tech
Co-investorsLaguna InvestmentLotte VenturesSolidus InvestmentSmilegate Investment
EnerzAI is an AI company, founded in 2019, that provides technology to improve AI model performance across accuracy, speed, cost efficiency, and sustainability.
AI & Machine LearningDeep TechIoTSeoul, KR
Daniel Hanhim Chang(Founder)inHanhim Chang(Founder)
Co-investorsAscendo VenturesSpringCampKorea Development BankSBI Investment
Korean aesthetic-medicine platform, operated by Healing Paper, connecting users with clinics for treatment information and bookings.
Co-investorsAtinum Investment Co. Ltd.Kiwoom InvestmentKT investment Inc.KT Strategic Investment Fund 4Aju IB InvestmentDSC Investment+4 more
Korea Investment Holdings is a financial holding company centered on investment banking, publishing quarterly earnings results, regulatory disclosures, and annual reports for customers and shareholders.
FintechSeoul, KR
Co-investorsMirana Ventures
Pine Tree Therapeutics develops therapies based on targeted protein degradation, with a focus on addressing drug resistance.
BiotechCambridge, US
Ho-Juhn Song(Founder)Ho-Juhn Song, Ph.D(Co-Founder & Chief Executive Officer)
Co-investorsAtinum Investment Co. Ltd.DSC InvestmentSchmidtSmilegate InvestmentSTIC InvestmentsSTIC Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.















